Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Join SI Premium – FREE
Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.79), $0.17 better than the analyst estimate of ($0.96).
For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- After-Hours Stock Movers: FDX, CBRS, NKE
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
